Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,129-16,140 of 23,847
Drug study icon
CompletedNCT03256162

Ketamine as an Adjunctive Therapy for Major Depression

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Dublin
Depression, BipolarityDrugA study involving a medication or substance.Over 18 Years
Countries
Ireland
Sponsor
St Patrick's Hospital, Ireland
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT04939649

Ketamine As an Adjunctive Therapy for Major Depression (2)

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Dublin
Depression, BipolarityDrugOver 18 Years
Countries
Ireland
Sponsor
University of Dublin, Trinity College
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT01881763

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Glen Oaks
Depression, BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Northwell Health
Condition
Depression, Bipolarity
Drug study icon
Active Not RecruitingNCT03573349

Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

This study is looking at whether Ketamine can help people with depression, Treatment Resistant Depression, or Depression in bipolarity. Participants take part in Ketamine and complete follow-up assessments.

In Rochester
Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT01101659

Ketamine Challenge Study With JNJ-40411813

This summary needs review. Please check the official study record and contact the research team for details.

In Neuss
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Germany
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT06736769

Ketamine Effects on Learning In Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Eating disordersDrugFrom 16 Years to 26 Years
Countries
United States
Sponsor
Amanda Downey, MD
Condition
Eating disorders
Drug study icon
CompletedNCT02094898

Ketamine for Depression and Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In Rochester
Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT05051449

Ketamine for OUD and Comorbid Depression (OUDCD)

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Depression, AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Depression, Addiction
Drug study icon
TerminatedNCT06111339

Ketamine for OUD and Suicide prevention in the ED

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Suicidality, AddictionDrugOver 18 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Suicidality, Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.